(Q44206781)

30 November 2017

title

Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions (English)

1 reference

30 November 2017

Ekström J

1

1 reference

30 November 2017

Hu KF

series ordinal

2

1 reference

30 November 2017

Bengtsson KL

series ordinal

3

1 reference

30 November 2017

Morein B

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

30 November 2017

1 reference

30 November 2017

volume

17

1 reference

30 November 2017

issue

20-21

1 reference

30 November 2017

page(s)

2690-2701

1 reference

The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

On the structure of immune-stimulating saponin-lipid complexes (iscoms)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

STRUCTURE AND ASSEMBLY OF MACROMOLECULAR LIPID COMPLEXES COMPOSED OF GLOBULAR MICELLES

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-beta-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Iscoms Containing PurifiedQuillajaSaponins Upregulate both Th1-like and Th2-like Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

The anatomical basis of intestinal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900052-3

7 January 2021

10.1016/S0264-410X(99)00052-3

Identifiers

DOI

1 reference

30 November 2017

1 reference